Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The small EDRL-rich factor 1 protein pseudogene (ENSG00000260443) is a segment of DNA resembling the gene for small EDRL-rich factor 1 protein but is classified as a pseudogene, meaning it does not encode a functional protein product. Pseudogenes commonly result from gene duplication or retrotransposition events and generally lack the regulatory elements or intact coding potential required for normal gene function. While some pseudogenes are transcribed into noncoding RNAs with potential regulatory roles, the majority, including this locus, are nonfunctional and not therapeutic or disease targets. Pseudogenes may complicate genetic studies due to sequence similarity with functional genes, but they do not themselves contribute protein or therapeutic action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small EDRL-rich factor 1 protein pseudogene (ENSG00000260443).